| Title |
|
Temozolomide-associated liver fibrosis |
|
|
| Publication Date |
|
| Author(s) |
|
| Subject |
|
| Type of document |
|
| OrcId |
|
| DOI |
|
| Abstract |
|
Temozolomide is generally well tolerated and severe hepatic toxicities associated with temozolomide are rare. We report a case of liver fibrosis in a patient on temozolomide for the treatment of GBM. This article is protected by copyright. All rights reserved. |
|
|
| Link |
|
| Citation |
|
The Journal of Clinical Pharmacology 2016; 56(11): 1448-1449 |
|
|
| Jornal Title |
|
The Journal of Clinical Pharmacology |
|
|
